Privia Health Group

Privia Health Group, Inc. engages in the provision of healthcare services. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experience, and reward doctors for delivering care both in-person and via its Privia Platform, virtual care settings. The company was founded by Jeffrey Butler on November 7, 2007 and is headquartered in Arlington, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Privia Health Group reports robust Q1 performance and growth outlook

Privia Health Group delivered strong financial performance in Q1 2023, with growth in key metrics and a reaffirmation of guidance.
The company faces challenges in maintaining value-based care penetration and addressing analyst inquiries on market performance.
However, Privia Health's strategic focus on expansion, performance improvement, and shared savings generation presents promising opportunities.
Overall, Privia Health's resilience, growth trajectory, and strategic initiatives position them well for future success in the healthcare industry.

Privia Health Group reports robust Q2 growth and strategic expansion

Privia Health Group's Q2 performance reflects strong financial growth, operational stability, and strategic expansion into new markets and care models.
While facing challenges such as increased AR and market entry costs, the company's focus on value-based care and operational optimization positions it for long-term success.
With a robust leadership team, steady provider retention, and a clear growth strategy, Privia is well-positioned to capitalize on opportunities in value-based care and market expansion.

Privia Health Group excels in Q3, poised for growth

Privia Health Group's Q3 performance reflects robust growth in providers, patients, and financial metrics, underpinning its competitive strength and market positioning.
While facing challenges in maintaining growth rates and managing diverse healthcare segments, Privia's strategic focus on expansion and innovation presents growth opportunities.
With a solid financial foundation, innovative business model, and optimistic outlook, Privia is poised for continued success and value creation in the healthcare industry.

Privia Health Group excels in 2023, eyes growth amid challenges

Privia Health Group's strong financial performance, stable cash position, and strategic focus on growth and profitability position it well for future success.
While facing challenges in managing value-based risk arrangements and revenue declines from renegotiated contracts, Privia is adapting and pursuing growth opportunities.
With a solid patient base, prudent financial management, and a clear growth strategy, Privia is navigating market challenges and aiming for continued success in 2024.

Privia Health Group reports robust Q1 performance and eyes growth

Privia Health Group's Q1 2024 performance reflects strong growth and profitability, supported by a robust balance sheet and strategic focus on primary care-centric networks. While facing challenges from certain market exits, the company is well-positioned to capitalize on opportunities in risk arrangements and program enhancements for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Arvinas Inc

Academy Sports and Outdoors

Boot Barn Hlds

CymaBay Therapeutics

Flywire Corp

Guardant Health Inc

Immunovant Inc

Rocket Pharma

Viridian Therapeutics

Wall Street's best small-cap stocks to buy include pharma, biotech and specialty retail names.

Best Small-Cap Stocks to Buy for 2024 and Beyond

ARLINGTON, Va., Dec. 12, 2023 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that its management team plans to present at the 42nd Annual J.P.

Privia Health to Participate in the J.P. Morgan Healthcare Conference

NASHVILLE, Tenn.--(BUSINESS WIRE)--Calm Waters AI, a fully autonomous, artificial intelligence Evaluation & Management (E/M) coding application for providers, has finalized an agreement with Privia Health™, which supports provider groups in delivering more efficient and effective patient care. Under the agreement, provider groups affiliated with Privia can implement and use Calm Waters AI at a discounted subscription rate. The Calm Waters AI software solution is designed to eliminate clinic.

Calm Waters AI Announces Agreement with Physician-Led Privia Health

Privia Health Group, Inc (NASDAQ:PRVA ) Q3 2023 Earnings Call Transcript November 3, 2023 9:00 AM ET Company Participants Robert Borchert - SVP, Investor & Corporate Communications Parth Mehrotra - President and CEO David Mountcastle - CFO Conference Call Participants Joshua Raskin - Nephron Research Elizabeth Anderson - Evercore ISI Jailendra Singh - Truist Securities Richard Close - Canaccord Genuity Brian Tanquilut - Jefferies Adam Ron - Bank of America Jack Senft - William Blair Benjamin Mayo - Leerink Partners Jeffrey Garro - Stephens Inc. Gary Taylor - Cowen Inc Jamie Perse - Goldman Sachs Jessica Tassan - Piper Sandler David Larsen - BTIG Operator Good day, and thank you for standing by. Welcome to the Privia Health Third Quarter Conference Call.

Privia Health Group, Inc (PRVA) Q3 2023 Earnings Call Transcript

Omnicell

Investors interested in Medical Info Systems stocks are likely familiar with Omnicell (OMCL) and Privia Health (PRVA). But which of these two companies is the best option for those looking for undervalued stocks?

OMCL vs. PRVA: Which Stock Should Value Investors Buy Now?

Privia Health (PRVA) came out with quarterly earnings of $0.05 per share, missing the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.01 per share a year ago.

Privia Health (PRVA) Q3 Earnings Miss Estimates

Practice Collections +18.2% com pared to 3Q'22 Implemented Providers +14.2% compared to 3Q'22 Company Updated Full Year 2023 Guidance ARLINGTON, Va., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the third quarter and nine month periods ended September 30, 2023.

Privia Health Reports Third Quarter 2023 Financial Results; Announces New Market Entry in South Carolina

ARLINGTON, Va., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it plans to release financial results for its third quarter and nine-month periods ended September 30, 2023 before market open on Friday, November 3, 2023.

Privia Health to Report Third Quarter 2023 Results on Friday, November 3

GE HealthCare Technologies Inc

Investors with an interest in Medical Info Systems stocks have likely encountered both GE HealthCare Technologies (GEHC) and Privia Health (PRVA). But which of these two stocks is more attractive to value investors?

GEHC or PRVA: Which Is the Better Value Stock Right Now?

Privia Health will leverage Navina's AI platform to enhance provider workflows and support value-based care NEW YORK , Sept. 14, 2023 /PRNewswire/ -- Navina, the artificial intelligence (AI)-powered primary care platform that transforms complex, fragmented patient data into actionable insights at the point of care, today announced a partnership with Privia Health Group, Inc. (Nasdaq: PRVA), a leading technology-driven physician enablement company.

Navina and Privia Health Join Forces to Empower Physicians with Transformative AI Technology

ARLINGTON, Va., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that its management team plans to participate in a Q&A session at the Morgan Stanley Global Healthcare Conference on Wednesday, September 13, 2023 beginning at 12:15 pm ET.

Privia Health to Participate in the Morgan Stanley Healthcare Conference

Privia ACOs Delivered Total Annual Average Expenditures 8% Lower than Median MSSP ACO and 19% Lower than Total Fee-For-Service Medicare

Privia Health Reports Results in CMS' Medicare Shared Savings Program for the 2022 Performance Year

Privia Health Group, Inc. shows growth in key business metrics and can unlock risk capital for equity investors this year. Q2 financials demonstrate top-line growth, gross margins, and critical unit economics. The company's asset-light business model drives economic value and supports an upside view on market value in my view.

Privia Health: Unit Economics Stretching Higher At Qualified Growth Rates (Rating Upgrade)

Privia Health Group, Inc. (NASDAQ:PRVA ) Q2 2023 Earnings Conference Call August 3, 2023 8:30 AM ET Company Participants Parth Mehrotra - President and CEO David Mountcastle - CFO Robert Borchert - SVP, Investor & Corporate Communications Conference Call Participants Jailendra Singh - Truist Securities Lisa Gill - J.P. Morgan Sameer Patel - Evercore ISI Richard Close - Canaccord Genuity Inc. Taji Phillips - Jefferies Group Jamie Perse - Goldman Sachs Jeff Garro - Stephens Inc. Andrew Mok - UBS David Larsen - BTIG Jessica Tassan - Piper Sandler Whit Mayo - SVB Securities Ryan Langston - TD Cowen Sandy Draper - Guggenheim Partners Ryan Daniels - William Blair Thomas Kelliher - RBC Capital Markets Operator Good day, and thank you for standing by.

Privia Health Group, Inc. (PRVA) Q2 2023 Earnings Call Transcript

Privia Health (PRVA) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to loss of $0.10 per share a year ago.

Privia Health (PRVA) Q2 Earnings and Revenues Surpass Estimates

ARLINGTON, Va., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the second quarter and six month periods ended June 30, 2023.

Privia Health Reports Second Quarter 2023 Financial Results

Distinguished Healthcare Leader Dave Wichmann and Seasoned CHRO Pam Kimmet to Join Board Distinguished Healthcare Leader Dave Wichmann and Seasoned CHRO Pam Kimmet to Join Board

Privia Health Announces Changes to Board of Directors

Investors with an interest in Medical Info Systems stocks have likely encountered both GE HealthCare Technologies (GEHC) and Privia Health (PRVA). But which of these two stocks offers value investors a better bang for their buck right now?

GEHC vs. PRVA: Which Stock Is the Better Value Option?

ARLINGTON, Va., July 11, 2023 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it plans to release financial results for its second quarter and six-month periods ended June 30, 2023 before market open on Thursday, August 3, 2023.

Privia Health to Report Second Quarter 2023 Results on Thursday, August 3

DURHAM, N.C., July 11, 2023 (GLOBE NEWSWIRE) -- Velocity Clinical Research (“Velocity”), the leading multi-specialty clinical sites business, and Privia Health (Nasdaq: PRVA), a physician enablement company serving more than 3,700 providers and 4.4 million patients, today announced a partnership to open embedded clinical research sites within Privia's practice network.

Velocity and Privia Health Enter Partnership to Embed Clinical Research Into Practice Sites

ARLINGTON, Va,, June 29, 2023 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that Adam Boehler, founder and Managing Partner of Rubicon Founders, will join the Company's Board of Directors effective July 1, 2023. He will replace Will Sherrill, Principal with Pamplona Capital, who is resigning his Board seat effective July 1, 2023 following Pamplona's sale of its ownership position in Privia Health through a secondary offering that closed on May 8, 2023. Parth Mehrotra, currently the Company's President and Chief Operating Officer, will also join the Board effective July 1, 2023, the date when he becomes the Company's CEO. Current CEO Shawn Morris, who is retiring, will remain on the Board. In connection with these elections, the size of the Board was increased to ten directors.

Privia Health Announces Expansion of and Changes to Board of Directors

PRVA had a strong start to the year with solid core operations and expansion into new markets, leading to a reaffirmed FY23 guidance. The platform contribution in 1Q23 exceeded expectations, with potential for modest upside surprise to the FY23 guidance, and capitated revenue grew by over 60% YoY, indicating a promising future profit driver. I expect the growth of Capitated book to be an upside catalyst once it starts to generate meaning profits.

Privia Health Group: Platform Contribution And Capitated Book Performed Strongly

ARLINGTON, Va., May 31, 2023 (GLOBE NEWSWIRE) --  Privia Health Group, Inc. (Nasdaq: PRVA), today announced that its management team plans to participate in the following investor conferences:

Privia Health to Participate in Upcoming Investor Conferences

Privia Health Group, Inc. (NASDAQ:PRVA ) Q1 2023 Results Conference Call May 4, 2023 8:30 AM ET Company Participants Robert Borchert - SVP, Investor and Corporate Communications Shawn Morris - CEO Parth Mehrotra - President and COO David Mountcastle - CFO Conference Call Participants Lisa Gill - JPMorgan A.J. Rice - Credit Suisse Andrew Mok - UBS Gary Taylor - Cowen Whit Mayo - SVB Jessica Tassan - Piper Sandler David Larsen - BTIG Richard Close - Canaccord Jamie Perse - Goldman Sachs Joshua Raskin - Nephron Research Brian Tanquilut - Jefferies Adam Ron - Bank of America Jailendra Singh - Truist Jeff Garro - Stephens Ryan Daniels - William Blair Operator Good day, and thank you for standing by.

Privia Health Group, Inc. (PRVA) Q1 2023 Earnings Call Transcript

- Investors include Durable Capital Partners LP and Rubicon Founders LLC ARLINGTON, Va., May 04, 2023 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA), a technology-driven, national physician enablement company, today announced the upsized pricing of an underwritten secondary offering of 42,561,196 shares of common stock by certain selling stockholders at a price of $22.00 per share.

News for Privia Health Group Stock (PRVA)